Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding
Clinical trial NCT02998775 · COMPLETED
Trial details
- NCT number
- NCT02998775
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-02
- Primary completion
- 2017-07-08
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.